Meipeng Zhu
- Orthopedics and Sports Medicine top 10%
- Bone and Joint Diseases 3
-
- Vitamin D Research Studies 2
-
- Bone Metabolism and Diseases 9
- Natural product bioactivities and synthesis 2
-
- Bone health and treatments 4
-
- Bone Tissue Engineering Materials 2
-
- Liver Disease Diagnosis and Treatment 2
-
- Osteoarthritis Treatment and Mechanisms 2
- Journals
- Biochemical Pharmacology (2 papers)Cell Metabolism (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Meipeng Zhu
19 papers receiving 358 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Orthopedics and Sports Medicine 77
- Pathology and Forensic Medicine 56
- Molecular Biology 170
- Cancer Research 33
- Pharmacology 35
Countries citing papers authored by Meipeng Zhu
This map shows the geographic impact of Meipeng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meipeng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meipeng Zhu more than expected).
Fields of papers citing papers by Meipeng Zhu
This network shows the impact of papers produced by Meipeng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meipeng Zhu. The network helps show where Meipeng Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meipeng Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 20 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axisbreakdown → | 2024 | 48 |
| 7 | 2023 | 2 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 25 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 36 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2021 | 72 | |
| 19 | 2019 | 21 | |
| 20 | 2018 | 38 |
About Meipeng Zhu
Meipeng Zhu is a scholar working on Orthopedics and Sports Medicine, Pharmacology and Pathology and Forensic Medicine, having authored 21 papers that have together received 359 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (9 papers), Bone health and treatments (4 papers), Bone and Joint Diseases (3 papers), Bone Tissue Engineering Materials (2 papers), Vitamin D Research Studies (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (77 citations), Pathology and Forensic Medicine (56 citations) and Molecular Biology (170 citations). Meipeng Zhu has collaborated with scholars based in China and United States. Frequent co-authors include Yimin Dong, Honglei Kang, Kehan Song, Renpeng Peng, Qian Guo, Feng Li, Hanfeng Guan, Yayun Zhang, Pengju Wang and Feng Li. Their work appears in journals such as Biochemical Pharmacology, Cell Metabolism, Frontiers in Cell and Developmental Biology, Cell Death and Disease and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.